Baiyao, Pien Tze Huang and Ejiao are the core assets of our country, and they are all tried and tested things. Among these companies, Baiyao is the best one at present, and Pien Tze Huang is learning Baiyao. The shareholding structure of Baiyao is also the best. So in the long run, taking Baiyao is very safe.
2. Sino-Singapore pharmaceutical industry
Zhongxin Pharmaceutical is a century-old shop. If we trace back to history, its Darentang and Lerentang are the sources of Beijing Tongrentang. From the brand point of view, Zhongxin Pharmaceutical's quick-acting jiuxin pill is a state secret formula.
However, the performance growth of Sino-Singapore Pharmaceutical is not smooth. After the net profit increased by 26. 17% in 20 16, the net profit decreased by 6. 17% year-on-year. Last year, the net profit increased to 12.39%, and the net profit in the first quarter of this year increased by 29.62% year-on-year.
Extended data:
Medical investment approval
Economic concession thought
Adhering to the concept of value investment, Linyuan pursues long-term steady appreciation, and the investment target is a monopoly enterprise with absolute competitive advantage. He once said that the advantage of Pien Tze Huang is that natural musk is approved by the state, which is not only a monopoly, but also a unique pricing power! This coincides with Buffett's most classic investment philosophy-economic franchising.
Be needed by people-the treatment of liver disease has a unique effect.
Pien Tze Huang series products include Pien Tze Huang, Pien Tze Huang capsule and other drugs for liver diseases, which are suitable for acute and chronic viral hepatitis and carbuncle caused by heat toxin and blood stasis, and have medical and health care functions. At present, the prevalence rate of adult fatty liver in China has reached 12.5%-35.4%, which is the largest liver disease in China. Pien Tze Huang has his own unique curative effect in treating liver diseases.